| 000 | 01726 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514020304.0 | ||
| 264 | 0 | _c20011228 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1006/gyno.2001.6442 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHasenburg, A | |
| 245 | 0 | 0 |
_aAdenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cDec 2001 |
||
| 300 |
_a549-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcyclovir _xpharmacokinetics |
| 650 | 0 | 4 |
_aAdenoviridae _xenzymology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSecond-Look Surgery |
| 650 | 0 | 4 |
_aThymidine Kinase _xgenetics |
| 650 | 0 | 4 |
_aTopotecan _xpharmacokinetics |
| 700 | 1 | _aTong, X W | |
| 700 | 1 | _aFischer, D C | |
| 700 | 1 | _aRojas-Martinez, A | |
| 700 | 1 | _aNyberg-Hoffman, C | |
| 700 | 1 | _aKaplan, A L | |
| 700 | 1 | _aKaufman, R H | |
| 700 | 1 | _aRamzy, I | |
| 700 | 1 | _aAguilar-Cordova, E | |
| 700 | 1 | _aKieback, D G | |
| 773 | 0 |
_tGynecologic oncology _gvol. 83 _gno. 3 _gp. 549-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/gyno.2001.6442 _zAvailable from publisher's website |
| 999 |
_c11647592 _d11647592 |
||